KFS
ABOS icon

Kelly Financial Services’s Acumen Pharmaceuticals ABOS Stock Holding History

Kelly Financial Services’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-944
Closed -$2.29K – 116
2024
Q2 		$2.29K Hold
944
– – ﹤0.01% 573
2024
Q1 		$3.82K Hold
944
– – ﹤0.01% 524
2023
Q4 		$3.63K Hold
944
– – ﹤0.01% 513
2023
Q3 		$3.92K Hold
944
– – ﹤0.01% 478
2023
Q2 		$4.54K Hold
944
– – ﹤0.01% 457
2023
Q1 		$3.83K Buy
+944
New +$4.93K ﹤0.01% 464

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Kelly Financial Services's ABOS Position: Q3 2024 in Review

Kelly Financial Services sold out of Acumen Pharmaceuticals (ABOS) in Q3 2024, closing a stake of 944 shares — an estimated $2.29K sold.

Kelly Financial Services first reported a position in ABOS in Q1 2023 and held it in 6 quarters. The position peaked at $4.54K in Q2 2023. 73 funds tracked by Wall St. Rank hold ABOS as of Q3 2024.

  • Kelly Financial Services reported no remaining Acumen Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 944 Acumen Pharmaceuticals shares in Q3 2024, an estimated $2.29K.
  • Kelly Financial Services first reported a position in Acumen Pharmaceuticals in Q1 2023 and held it in 6 quarters.
  • Kelly Financial Services's Acumen Pharmaceuticals position peaked at $4.54K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.